Editas Medicine (NASDAQ:EDIT) Releases Earnings Results, Beats Estimates By $0.08 EPS
Editas Medicine (NASDAQ:EDIT – Get Rating) released its earnings results on Friday. The company reported ($0.71) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.79) by $0.08, Briefing.com reports. The firm had revenue of $9.90 million for the quarter, compared to analyst estimates of $3.29 million. Editas Medicine had a negative […]